ArticleJournal of pharmacopuncture2025
Management of Perennial Allergic Rhinitis Complicated by Rhinosinusitis Using Ultrasound-Guided Sphenopalatine Ganglion Acupuncture and Modified Socheongryong-tang: two CARE-compliant case reports.
Article in Journal of pharmacopuncture, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [A Randomized Controlled Clinical Trial of Acupuncture at the Sphenopalatine Ganglion for the Treatment of Allergic Rhinitis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are common upper respiratory tract diseases that frequently coexist. While not life-threatening, these conditions significantly diminish quality of life, impose substantial socioeconomic burdens due to their chronic and recurrent nature, and negatively impact mental health. In some cases, AR and CRS have been associated with severe outcomes, including suicidal tendencies. This report presents two cases of women aged 42 and 37 years who experienced recurrent AR and CRS symptoms, such as persistent nasal congestion, rhinorrhea, which led to difficulties in conversation during meals and sleep disturbances, for over 20 years, despite undergoing conventional treatments. Both patients received an 8-12 week treatment regimen consisting of Socheongryong-tang (SCRT) and ultrasound-guided acupuncture targeting the sphenopalatine ganglion (SPG). Treatment efficacy was assessed using nasal endoscopic findings, Rhinoconjunctivitis Quality of Life Questionnaire scores, and Total Nasal Symptom Scores. Significant post-treatment improvements were observed, and these effects persisted for 3 months after treatment cessation, with no significant adverse events reported. While Intranasal corticosteroids are the standard treatment for AR and CRS, approximately 30% of patients either experience insufficient symptom relief or discontinue their use due to adverse effects, often leading to symptom relapse. In contrast, the combination of SCRT and SPG-targeted ultrasound-guided acupuncture may offer a promising alternative treatment option, demonstrating sustained symptom improvement without significant adverse effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.